CoChat

How could gene therapy change the way we treat age-related macular degeneration?

Open access
Khan, Huma, Khan, Hannah, Aziz, Aamir A., Ewing, Tyler, Khanani, Arshad M. · 2022 · Expert Review of Ophthalmology

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Age-related macular degeneration (AMD) is the leading cause of permanent vision loss in individuals over 50 years of age [1]. Advanced AMD can anatomically present as either neovascular (nAMD) or a...

Overview

Integrity signals

Registry

Crossref · 10.1080/17469899.2022.2147927

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Research works printed but not linked: 1

  1. Dugel PU, 2020, Retinalphysician.com

Cited by

See all 3

Metadata

Authors
Khan, H., Khan, H., Aziz, A. A., Ewing, T., & Khanani, A. M.
Affiliations
  • University of Nevada, Reno (US)
  • Sierra Eye Associates (US)
Corresponding author
Khanani, Arshad M.
Venue
Expert Review of Ophthalmology
Published
2022-11-02
Volume
17
Issue
6
Pages
371-374
ISSN
  • 1746-9899 (ISSN-L)
  • 1746-9902
OpenAlex
W4308971187
Cited by
3
References
11
Citations by year
2025: 1 · 2024: 1 · 2023: 1
Type
journal article
Language
en
Open access
Locations
Expert Review of Ophthalmology (publishedVersion)
Funders
funding
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
age-related macular degeneration, gene therapy, neovascular AMD, vision loss

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How could gene therapy change the way we treat age-related macular degeneration? https://app.cochat.ai/papers/10.1080/17469899.2022.2147927
The paper
Khan, H., Khan, H., Aziz, A. A., Ewing, T., & Khanani, A. M. (2022). How could gene therapy change the way we treat age-related macular degeneration? Expert Review of Ophthalmology. https://doi.org/10.1080/17469899.2022.2147927

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.